Solid State Form Characterization for Drug Development
Characterizing an API’s different salt forms and polymorphs is an essential drug development task. The successful preclinical assessment and product development can…
Renejix – Small Molecule CDMO (USA)
Characterizing an API’s different salt forms and polymorphs is an essential drug development task. The successful preclinical assessment and product development can…
Enhancing Drug Solubility: Understanding Amorphous Solid Dispersions In recent years, amorphous solid dispersions (ASDs) have gained significant popularity and proven to be…
Creating controlled release drugs, which release medicine at a specific rate or location in the digestive system, can be difficult. Physiologically-based pharmacokinetic…
Drugs will not work in patients who cannot or do not take them. Non- adherence to prescribed medication regimens is a major…
“New drugs receiving expedited approval have shorter timelines, which can create unique challenges for development and manufacturing. Joe Dukich, director of operations…
The selection of an appropriate technology for a product is a critical decision that influences its commercial success. The process of technology…
Lipid-based drug delivery systems are being recognized as an immensely promising and groundbreaking platform for the development of drug products that integrate…
To ensure the physical and chemical stability of Lipid-Based Formulations (LBFs), it is essential to find a delicate balance between the formulation…
LIQUID IN BOTTLE (LIB) The use of Liquid in Bottle (LIB) as a delivery method provides unparalleled flexibility, eliminating the need for…
In-Depth Understanding of LBDDS The pharmaceutical industry’s exploration into lipid-based drug delivery systems (LBDDS) is a growing trend. Thanks to initiatives like…